News Effectiveness and Costs of Bevacizumab vs Ranibizumab in DME by Medscape • 2015/09/07 • 0 Comments A new head-to-head trial compares the efficacy and economic value of these two anti-VEGF agents for DME. Which one has the edge? BMC Ophthalmology Full Story →